Since genetic mutations are the driving force behind tumor phenotype, e.g., metabolic reprogramming enabled by mutated KEAP1, to support rapid growth and proliferation, thus it is rational to assume that KEAP1-NRF2 mutations in the cancer cell-of-origin promote a metabolic profile that shapes the TIME. The gene discussed is NFE2L2; the disease is neoplasm.